News Quantified

RHHBY – roche holding ltd s/adr (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Genentech's Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD [Yahoo! Finance]

Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD

Healthy diets spark lung cancer risk in non-smokers as pesticides loom [FOX News]

FDA Accepts Application for Genentech's Gazyva for the Treatment of the Most Common Form of Lupus [Yahoo! Finance]

FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus

Top News Gainers

3/13 UPDATE 1-European stock markets calm after pandemic-driven crash [Reuters] 13.0%

3/24 Roche says limit tests to people with coronavirus symptoms [Reuters] 5.4%

3/16 Roche begins shipments of first 400,000 COVID-19 tests to laboratories across US to begin patient testing under FDA Emergency Use Authorization 5.2%

3/4 MORNING BID-Rate cuts no panacea for virus damage [Reuters] 4.9%

3/19 Roche to test Acterma as a treatment for COVID-19 [MarketWatch] 4.7%

4/13 Researchers on the hunt for coronavirus treatments [CBS News] 3.6%

3/9 FDA OKs new use of Boehringer Ingelheim's Ofev [Seeking Alpha] 3.4%

4/22 Coffee, chocolates and pills shield Swiss stocks from virus rout [Reuters] 3.0%

2/5 Is Illumina Stock a Buy? [The Motley Fool] 2.8%

1/30 BRIEF-Roche Q4 China Sales Fell Amid Inventory Cuts, Sees 2020 Double-Digit Growth [Reuters] 2.5%

Top News Decliners

3/12 BRIEF-Roche Gets EU Approval For Chronic Lymphocytic Leukaemia Treatment [Reuters] -9.0%

3/13 Roche jumps after coronavirus test gets FDA approval [Yahoo! Finance News] -7.4%

3/19 Roche to test Actemra as a treatment for COVID-19 [MarketWatch] -7.4%

3/7 Belreca: An Investment Holding Trading At A Discount With The Overhead Cost Of An ETF [Seeking Alpha] -5.8%

3/11 BRIEF-Roche Receives FDA Approval For Cervical Cancer Prevention Test [Reuters] -4.3%

3/17 Coronavirus testing shouldn’t be this complicated [The Verge] -4.0%

3/23 Roche CEO says broad coronavirus testing in U.S. could take weeks - CNBC [Reuters] -3.5%

4/28 Coronavirus antibody tests have "really terrible" accuracy, researcher says [CNN] -3.3%

2/27 Roche To Top $66 Billion In Sales By 2020, Led By Neuroscience [Forbes] -3.2%

1/24 UPDATE 1-Roche's Tecentriq fails trial in form of urothelial cancer [Reuters] -2.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day